Stay updated on Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial

Sign up to get notified when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    New location sections were added for Illinois, New York, North Carolina, Pennsylvania, Texas, Gauteng, West Cape, and Patumwan, replacing the previous location blocks. The page revision updated from v3.3.2 to v3.3.3 and the HHS Vulnerability Disclosure footer was removed.
    Difference
    0.8%
    Check dated 2025-12-23T22:05:56.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The only change is a version update: Revision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T11:20:37.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The government funding status notice at the top of the page was removed. This change does not affect the study details, eligibility criteria, or results information.
    Difference
    0.3%
    Check dated 2025-11-18T07:11:12.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Minor layout and wording adjustments to the Study Details page; core study information such as outcomes, eligibility criteria, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:10:20.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Major: new operating-status notice due to funding lapse and NIH Clinical Center openness; major version upgrade to v3.2.0. Minor: removal of v3.1.0 tag, no other content changes.
    Difference
    2%
    Check dated 2025-10-06T05:59:49.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T03:13:02.000Z thumbnail image

Stay in the know with updates to Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.